Amsal Delalic

GuardG
GTD
Injury Knee
2025 CBB Stats
PTS
0.0
REB
0.0
AST
0.0
STL
0.0
BLK
0.0
ROS Projections
PTS
REB
AST
STL
BLK
Unlock Our Projections
Jersey #52
Eligibility Sophomore
School Year Sophomore
Height 6'8"
Weight 215
DOB 7/24/2003
Born Tuzla,
Prev. School Pittsburgh
Will remain at DePaul
GDePaul
Knee
March 27, 2026
Delalic (knee) will remain at DePaul for the 2026-27 season, according to Nick Palazzolo of The DePaud.
ANALYSIS
Delalic didn't play for DePaul in the 2025-26 season due to a torn ACL, but he played in 21 games in the 2024-25 campaign. He figures to be part of the rotation in 2026-27 if he stays healthy.
Read More News
College Basketball Stats
Loading CBB Stats...
2024 CBB Game Log
2024
Calculate Stats Over Time
Just click on any two dates.
Scoring
FanDuel
DraftKings
Head2Head
Loading Game Log...
2025 CBB Split Stats
Loading CBB Stats...
Blue Demons Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
More Fantasy News
Out for season
GDePaul
Knee
June 30, 2025
Delalic has been ruled out for the season after suffering a torn ACL Monday, per Jon Rothstein of CBS Sports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Transferring to DePaul
GDePaul
April 18, 2025
Delalic has committed to DePaul for the 2025-26 season, Nick Palazzolo of The DePaulia reports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Leaving Steel City
GFree Agent
Transfer Portal
March 25, 2025
Delalic will enter the transfer portal, per VerbalCommits.com.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Will return Monday
GPittsburgh
Hand
November 8, 2024
Delalic (hand) didn't play on Friday night vs. Murray State but is set to return Monday versus Garnder-Webb, Christopher Carter of the Pittsburgh Post-Gazette reports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Out at least six weeks
GPittsburgh
Hand
September 26, 2024
Delalic is out for at least six weeks due to a hand injury, per Chris Peak of Rivals.
ANALYSIS
Subscribe now to instantly reveal our take on this news.